Vanguard Global Advisers
OM icon

Vanguard Global Advisers’s Outset Medical OM Stock Holding History

Vanguard Global Advisers’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.1K Hold
7,902
– – ﹤0.01% 3191
2026
Q1 		$30.3K Buy
+7,902
New +$32.4K ﹤0.01% 3190

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Vanguard Global Advisers's OM Position: Q2 2026 in Review

Vanguard Global Advisers held its Outset Medical (OM) position steady in Q2 2026 at 7,902 shares worth $34.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3191.

Vanguard Global Advisers first reported a position in OM in Q1 2026 and has held it in 2 quarters since. 92 funds tracked by Wall St. Rank hold OM as of Q2 2026.

  • Vanguard Global Advisers held 7,902 shares of Outset Medical worth $34.1K as of Q2 2026.
  • Vanguard Global Advisers left its Outset Medical share count unchanged in Q2 2026.
  • Outset Medical made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #3191 holding.
  • Vanguard Global Advisers first reported a position in Outset Medical in Q1 2026 and has held it in 2 quarters since.
  • 92 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.